In vitro and in vivo evaluation of riccardin D nanosuspensions with different particle size

Colloids and Surfaces B: Biointerfaces

Volumn 102, Issue , 2013, Pages 620-626

  Liu, Guangpu ^a   Zhang, Dianrui ^a   Jiao, Yang ^a   Guo, Hejian ^a   Zheng, Dandan ^a   Jia, Lejiao ^a   Duan, Cunxian ^a   Liu, Yue ^a   Tian, Xiaona ^a   Shen, Jingyi ^a   Li, Caiyun ^a   Zhang, Qiang ^b   Lou, Hongxiang ^a  

^a SHANDONG UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Nanocrystal; Nanosuspensions; Pharmacokinetics; Riccardin D; Tissue distribution

Indexed keywords

ANTICANCER ACTIVITIES; BOTTOM UP METHODS; CONTROL GROUPS; DIFFERENT SIZES; DISSOLUTION BEHAVIOR; ENDOTHELIAL SYSTEMS; IN-VITRO; INTRAVENOUS ADMINISTRATION; NANO-SUSPENSIONS; ORGANIC SOLUTIONS; POORLY WATER-SOLUBLE DRUGS; TISSUE DISTRIBUTIONS; TOP-DOWN METHODS; WISTAR RAT;

NANOCRYSTALS; PHARMACOKINETICS;

PARTICLE SIZE;

ANTINEOPLASTIC AGENT; RICCARDIN D; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; LUNG; MOUSE; NANOSUSPENSION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; SUSPENSION; TISSUE DISTRIBUTION;

ANIMALS; DRUG STABILITY; HEPATOPHYTA; MICE; NANOPARTICLES; PARTICLE SIZE; PHENYL ETHERS; RATS; RATS, WISTAR; SOLUBILITY; STILBENES;

MARCHANTIA POLYMORPHA; MUS; RATTUS NORVEGICUS;

EID: 84867774194     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.09.006     Document Type: Article

References (41)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer Stat. 2010, 60:277.
2. Dong M., Philippi C., Loretz B., Nafee N., Schaefer U.F., Friedel G., Ammon-Treiber S., Griese E.U., Lehr C.M., Klotz U. Int. J. Pharm. 2011, 419:33.
3. Wu X.Z., Cheng A.X., Sun L.M., Sun S.J., Lou H.X. Biochim. Biophys. Acta 2009, 1790:770.
4. Shi Y., Qu X., Liao Y., Xie C., Cheng Y., Li S., Lou H. Eur. J. Pharmacol. 2008, 584:66.
5. Wu X.Z., Chang W.Q., Cheng A.X., Sun L.M., Lou H.X. Biochim. Biophys. Acta 2010, 1800:439.
6. Sun C., Zhang Y., Xue X., Cheng Y., Liu H., Zhao C., Lou H., Qu X. Eur. J. Pharmacol. 2011, 667:136.
7. Xue X., Qu X.J., Gao Z.H., Sun C.C., Liu H.P., Zhao C.R., Cheng Y.N., Lou H.X. Invest. New Drugs 2010, 30:212.
8. Liu G., Zhang D., Jiao Y., Zheng D., Liu Y., Duan C., Jia L., Zhang Q., Lou H. Int. J. Pharm. 2012, 422:516.
9. Verma S., Gokhale R., Burgess D.J. Int. J. Pharm. 2009, 380:216.
10. Lipinski C.A. Am. Pharm. Rev. 2002, 5:82.
11. Yang W., Tam J., Miller D.A., Zhou J., McConville J.T., Johnston K.P., Williams R.O. Int. J. Pharm. 2008, 361:177.
12. Akers M.J. J. Pharm. Sci. 2002, 91:2283.
13. Strickley R.G. Pharm. Res. 2004, 21:201.
14. Vyas A., Saraf S. J. Incl. Phenom. Macrocyclic Chem. 2008, 62:23.
15. Gupta U., Agashe H.B., Asthana A., Jain N. Biomacromolecules 2006, 7:649.
16. Serajuddin A. Adv. Drug Deliv. Rev. 2007, 59:603.
17. Chen H., Khemtong C., Yang X., Chang X., Gao J. Drug Discov. Today 2011, 16:354.
18. Ebbesen M., Jensen T.G. J. Biomed. Biotechnol. 2006, 2006:1.
19. Yang W., Peters J.I., Williams R.O. Int. J. Pharm. 2008, 356:239.
20. Gao L., Zhang D., Chen M., Duan C., Dai W., Jia L., Zhao W. Int. J. Pharm. 2008, 355:321.
21. Liversidge G.G., Cundy K.C. Int. J. Pharm. 1995, 125:91.
22. Peters K., Leitzke S., Diederichs J., Borner K., Hahn H., Müller R., Ehlers S. J. Antimicrob. Chemother. 2000, 45:77.
23. Pignatello R., Bucolo C., Ferrara P., Maltese A., Puleo A., Puglisi G. Eur. J. Pharm. Sci. 2002, 16:53.
24. Jacobs C., Müller R.H. Pharm. Res. 2002, 19:189.
25. Muller R.H., Keck C.M. J. Biotechnol. 2004, 113:151.
26. Gao L., Liu G., Wang X., Liu F., Xu Y., Ma J. Int. J. Pharm. 2011, 404:231.
27. Sjöstrom B., Kronberg B., Carlfors J. J. Pharm. Sci. 1993, 82:579.
28. Merisko-Liversidge E., Liversidge G.G., Cooper E.R. Eur. J. Pharm. Sci. 2003, 18:113.
29. Wang Y., Zhang D., Liu Z., Liu G., Duan C., Jia L., Feng F., Zhang X., Shi Y., Zhang Q. Nanotechnology 2010, 21:155104.
30. Liu Y., Zhang D., Zou D., Wang Y., Duan C., Jia L., Xie P., Feng F., Wang F., Zhang X. J. Biomed. Nanotechnol. 2011, 7:621.
31. Simon B.H., Ando H.Y., Gupta P.K. J. Pharm. Sci. 1995, 84:1249.
32. Moghimi S.M., Hunter A.C., Murray J.C. Pharmacol. Rev. 2001, 53:283.
33. Jia L., Zhang D., Li Z., Duan C., Wang Y., Feng F., Wang F., Liu Y., Zhang Q. Colloids Surf. B Biointerfaces 2010, 80:213.
34. Liu Y., Zhang D., Duan C., Jia L., Xie P., Zheng D., Wang F., Liu G., Hao L., Zhang X. J. Microencapsul. 2012, 29:194.
35. Yang S.C., Lu L.F., Cai Y., Zhu J.B., Liang B.W., Yang C.Z. J. Control. Release 1999, 59:299.
36. Löbenberg R., Araujo L., von Briesen H., Rodgers E., Kreuter J. J. Control. Release 1998, 50:21.
37. Yamaguchi H., Watanabe K., Hayashi M., Awazu S. J. Pharm. Pharmacol. 1984, 36:766.
38. Mizushima Y., Hamano T., Yokoyama K. Ann. Rheum. Dis. 1982, 41:263.
39. Zhipeng C., Jiabi Z., Hongxuan C., Yan-yu X., Jun C., Bao-chang C. J. Drug Target 2010, 18:627.
40. Yao J., Zhou J.P., Ping Q.N., Lu Y., Chen L. Int. J. Pharm. 2008, 352:256.
41. Zheng D., Wang Y., Zhang D., Liu Z., Duan C., Jia L., Wang F., Liu Y., Liu G., Hao L. Cancer Lett. 2011, 307:158.